 | Talis Biomedical Corporation | |||
| NCM : TLIS || Location: United States | ||||
$9.0+0.55 (+6.51%) |
0.0 M | 9.0 - 9.0 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.013 M |
| March 15, 2024 | 0.014 M |
| Feb. 29, 2024 | 0.013 M |
| Feb. 15, 2024 | 0.014 M |
| Jan. 31, 2024 | 0.018 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -7.52 | -8.62 | -14.67% |
| 03/31/2023 | -11.17 | -9.90 | 11.36% |
| 12/31/2022 | -10.27 | -15.00 | -46.10% |
| 09/30/2022 | -11.93 | -14.70 | -23.18% |
| 06/30/2022 | -12.07 | -15.15 | -25.50% |
TLIS Basic Data
| Sector | Healthcare | Industry | Medical Devices |
| Shares Outstanding | 1.822M | Shares Float | 1.012M |
| Short Float | 0.013M | Market Cap | 16.40M |
| Institution ownership | 43.93% | Insider ownership | 8.307% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -34.12 | Forward EPS | -23.32 |